Detail of outcome
We received 39 responses to this call for evidence.
We have carefully considered all the submissions received and will be using this evidence to inform the final review report. The review is expected to submit its advice by 30 September 2018 and the report will be published shortly after.
We’re seeking information about evidence-based interventions (including epidemiological and regulatory/economic measures) for bTB control. This is part of the bTB strategy review’s evidence gathering phase and will only consider topics included in the review’s terms of reference. The review is not assessing the current bTB strategy, but looking at what should be prioritised in the future.
Responses must not be longer than 2 A4 pages (not including the list of references). Please indicate in your response whether you are responding as an individual or on behalf of an organisation.
In particular, we’d like to hear about:
- research considering how to improve deployment of existing bTB control interventions
- potential new approaches and tools/technologies to deal with bTB
- approaches taken to control bTB in other countries
- work on human TB that might be relevant to the review
Confidentiality and data protection
Information provided in response to this call for evidence, including personal information, may be subject to publication or release to other parties or to disclosure in accordance with the access to information regimes, for example the Freedom of Information Act 2000 (FOIA) and the Data Protection Act 1998.
If you want information, including personal data, which you provide to be treated as confidential, please say so clearly in writing when you send your response to the call for evidence and say why you need to keep these details confidential. If we receive a request for disclosure under the FOIA, we will take account of your explanation, but we cannot provide an assurance that confidentiality can be maintained in all circumstances. An automatic confidentiality disclaimer generated by our IT system will not, by itself, be regarded as a confidentiality request.
This call for evidence is being conducted in line with the “Consultation Principles” set out by the Better Regulation Executive guidance.
If you have any comments or complaints about the call for evidence process, please address them to: Consultation Co-ordinator, Room 629, Millbank, 17 Smith Square, London SW1P 3JR. Alternatively, please email: email@example.com.